Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
239.3 USD | +0.45% | +0.69% | +16.52% |
Mar. 14 | Cencora, Inc. Reaffirms Guidance for Year 2024 | CI |
Mar. 14 | Transcript : Cencora, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 08:30 AM |
Financials (USD)
Sales 2024 * | 292B | Sales 2025 * | 310B | Capitalization | 47.69B |
---|---|---|---|---|---|
Net income 2024 * | 2.05B | Net income 2025 * | 2.16B | EV / Sales 2024 * | 0.16 x |
Net cash position 2024 * | 97.06M | Net cash position 2025 * | 3.27B | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
22.7
x | P/E ratio 2025 * |
21
x | Employees | 44,000 |
Yield 2024 * |
0.85% | Yield 2025 * |
0.88% | Free-Float | 57.34% |
Latest transcript on Cencora, Inc.
1 day | +0.45% | ||
1 week | +0.69% | ||
Current month | +1.57% | ||
1 month | +3.28% | ||
3 months | +19.61% | ||
6 months | +33.67% | ||
Current year | +16.52% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Collis
CEO | Chief Executive Officer | 62 | 93-12-31 |
James Cleary
DFI | Director of Finance/CFO | 61 | 15-01-31 |
Jennifer Dubas
CMP | Compliance Officer | - | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathleen Hyle
BRD | Director/Board Member | 65 | 10-05-12 |
Director/Board Member | 74 | 08-09-24 | |
D. Mark Durcan
BRD | Director/Board Member | 62 | 15-09-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.85% | 2 M€ | +21.73% | - | |
1.83% | 144 M€ | +7.40% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 239.3 | +0.45% | 1,122,380 |
24-03-15 | 238.2 | +0.23% | 2,150,197 |
24-03-14 | 237.7 | +1.24% | 1,280,193 |
24-03-13 | 234.8 | -1.12% | 1,447,420 |
24-03-12 | 237.4 | -0.10% | 666,627 |
Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.52% | 47.47B | |
+2.15% | 200B | |
+1.55% | 111B | |
-2.51% | 68.39B | |
+8.57% | 50.29B | |
+8.45% | 45.04B | |
+10.61% | 28.87B | |
+7.68% | 28.45B | |
+12.38% | 28.38B | |
+21.46% | 28.32B |